RE:0.095 cents!!Pharmala's business is outside the US market so technically it really shouldn't matter what the FDA decision is. What matters is the direction other countries are going and if Pharmala will be an integral part in providing MDMA in those countries. I get that deals can take a long time to hammer out, but the lack of news releases about ANY progress within the company is becoming somewhat annoying, especially as the share price falls.